We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+6.02%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$483M
AUM Growth
+$12.7M
Cap. Flow
-$7.77M
Cap. Flow %
-1.61%
Top 10 Hldgs %
17.02%
Holding
376
New
4
Increased
1
Reduced
1
Closed
10

Top Buys

Rank Stock Value
1
STJ
St Jude Medical
STJ
+$404K
2
RIGL icon
Rigel Pharmaceuticals
RIGL
+$287K
3
DELL icon
Dell
DELL
+$271K
4
CVG
Convergys
CVG
+$213K
5
MAN icon
ManpowerGroup
MAN
+$207K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$1.69M
2
EMC
EMC CORPORATION
EMC
+$1.36M
3
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
+$1.33M
4
MDVN
MEDIVATION, INC.
MDVN
+$1.21M
5
ALK icon
Alaska Air
ALK
+$1.17M

Sector Composition

Rank Sector Weight
1 Technology 18.09%
2 Financials 14.81%
3 Healthcare 13.75%
4 Industrials 11.98%
5 Consumer Staples 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDVN
376
DELISTED
MEDIVATION, INC.
MDVN
– –
-20,000
Closed -$1.21M
12 13 14 15
16

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q3 2016 Portfolio in Review

As of Q3 2016, NJ State Employees Deferred Compensation Plan held 376 positions worth $483M, up 2.7% from $471M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q3 2016: portfolio turnover was 3.7%. NJ State Employees Deferred Compensation Plan opened 4 new positions and exited 10, leaving the 376-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • NJ State Employees Deferred Compensation Plan's largest Q3 2016 buy was St Jude Medical: 5,000 shares worth $399K.
  • NJ State Employees Deferred Compensation Plan added most to Rigel Pharmaceuticals in Q3 2016, an estimated $287K increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q3 2016 reduction was Sio Gene Therapies Inc. Common Stock, cutting an estimated $450K.
  • NJ State Employees Deferred Compensation Plan fully exited Biogen in Q3 2016, selling an estimated $1.69M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 17% of its $483M portfolio in Q3 2016.
  • NJ State Employees Deferred Compensation Plan opened 4 new positions and closed 10 in Q3 2016.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 2.7% quarter-over-quarter to $483M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2016, filed 21 Oct 2016.